HITACHI has announced the development of a machine learning-based outcome prediction and comparison technology that predicts with high accuracy the success and failure of various medication options for patients with type-2 diabetes mellitus, in collaboration with University of Utah Health.
The company said it drew on the knowledge and experience from within its staff as well as doctors, pharmacists and biomedical informaticists at the university.
The technology has the potential to support the selection of the most effective medication depending on multiple factors, the company claims.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Nov 17
